SAN DIEGO — Among ulcerative colitis patients in endoscopic remission, histologic inflammation increased the risk for loss of remission, according to a presentation at Digestive Disease Week 2022.
“In this large, multicenter, real-world study including both academic and community practices using standard-of-care reports, histologic inflammation — despite endoscopic remission — independently conveyed a two-fold increased risk for subsequent relapse within a year,” Benjamin Click, MD, MS, assistant professor at the University of Colorado Crohn’s and Colitis